Khiron Life Sciences Corp... (KHRNF)
PNK: KHRNF
· Real-Time Price · USD
0.00
-0.00 (-100.00%)
At close: Jun 05, 2025, 11:48 AM
Company Description
Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe.
It operates through Health Services, Medical Cannabis Products, and Wellbeing Products segments.
The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and cannabidiol (CBD) medical cannabis.
It also operates a network of health centers and satellite clinics under the ILANS and Zerenia brands; develops CBD-based cosmeceutical products under the Kuida brand name; and operates Zerenia clinic in Medellin and Peru.
Khiron Life Sciences Corp. was incorporated in 2012 and is headquartered in Vancouver, Canada.
Khiron Life Sciences Corp.
| Country | CA |
| IPO Date | Jan 8, 2021 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 310 |
| CEO | Dr. Alvaro Francisco Torres |
Contact Details
Address: 500 Burrard Street Vancouver, BC CA | |
| Website | https://khiron.ca |
Stock Details
| Ticker Symbol | KHRNF |
| Exchange | PNK |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | n/a |
| CUSIP Number | n/a |
| ISIN Number | CA49374L3065 |
| Employer ID | - |
| SIC Code | n/a |
Key Executives
| Name | Position |
|---|---|
| Dr. Alvaro Francisco Torres | Co-Founder, Chief Executive Officer & Director |
| Michael John O'Connor MA | Chief Financial Officer |
| Franziska Katterbach | President of Khiron Europe |
| Marco Algorta | Country Manager of Uruguay |
| Swapan Kakumanu ACA, ACWA, CGA | Corporate Secretary |